Efficacy and safety of nonsteroidal anti‐inflammatory drugs in Asian patients with knee osteoarthritis: summary of a randomized, placebo‐controlled study

por Essex, Margaret N., O'Connell, Michael A., Behar, Regina, Bao, Weihang
Publicado 2015

Safety of atorvastatin in Asian patients within clinical trials

por Chan, Juliana C. N., Kong, Alice P. S., Bao, Weihang, Fayyad, Rana, Laskey, Rachel
Publicado 2016

532. Nirmatrelvir/Ritonavir Versus Placebo in Unvaccinated and Vaccinated High Risk Patients

por Leister-Tebbe, Heidi, Bao, Weihang, Fountaine, Robert, Baniecki, Mary Lynn, Hendrick, Victoria, Wisemandle, Wayne, Hammond, Jennifer, Rusnak, James
Publicado 2023

Inflammatory Biomarkers, Death, and Recurrent Nonfatal Coronary Events After an Acute Coronary Syndrome in the MIRACL Study

por Zamani, Payman, Schwartz, Gregory G., Olsson, Anders G., Rifai, Nader, Bao, Weihang, Libby, Peter, Ganz, Peter, Kinlay, Scott
Publicado 2013

786. Effect of Nirmatrelvir/Ritonavir versus Placebo on COVID-19─Related Hospitalizations and Other Medical Visits

por Hammond, Jennifer, Leister-Tebbe, Heidi, Gardner, Annie, Abreu, Paula, Bao, Weihang, Wisemandle, Wayne, Ansari, Wajeeha, Simón Campos, Jesus Abraham, Pypstra, Rienk, Rusnak, James M
Publicado 2022

Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19

por Hammond, Jennifer, Leister-Tebbe, Heidi, Gardner, Annie, Abreu, Paula, Bao, Weihang, Wisemandle, Wayne, Baniecki, MaryLynn, Hendrick, Victoria M., Damle, Bharat, Simón-Campos, Abraham, Pypstra, Rienk, Rusnak, James M.
Publicado 2022

361. Evaluation of Resistance to Nirmatrelvir/ritonavir in Evaluation of Protease Inhibition for COVID-19 (EPIC) High-Risk and Standard-Risk Clinical Trials

por Lynn Baniecki, Mary, Guan, Shunjie, Wang, Zhenyu, Chen, Yan, Bao, Weihang, He, Wen, Dushin, Elizabeth, Hyde, Craig, Zhu, Yuao, Cardin, Rhonda D, Hammond, Jennifer, Menon, Sandeep, Allerton, Charlotte, Soares, Holly
Publicado 2023

Total Soluble and Endogenous Secretory Receptor for Advanced Glycation End Products as Predictive Biomarkers of Coronary Heart Disease Risk in Patients With Type 2 Diabetes: An Ana...

por Colhoun, Helen M., Betteridge, D. John, Durrington, Paul, Hitman, Graham, Neil, Andrew, Livingstone, Shona, Charlton-Menys, Valentine, Bao, Weihang, DeMicco, David A., Preston, Gregory M., Deshmukh, Harshal, Tan, Kathryn, Fuller, John H.
Publicado 2011

Prediction of Cardiovascular Events in Statin-Treated Stable Coronary Patients of the Treating to New Targets Randomized Controlled Trial by Lipid and Non-Lipid Biomarkers

por Arsenault, Benoit J., Barter, Philip, DeMicco, David A., Bao, Weihang, Preston, Gregory M., LaRosa, John C., Grundy, Scott M., Deedwania, Prakash, Greten, Heiner, Wenger, Nanette K., Shepherd, James, Waters, David D., Kastelein, John J. P.
Publicado 2014

Effect of atorvastatin on C-reactive protein and benefits for cardiovascular disease in patients with type 2 diabetes: analyses from the Collaborative Atorvastatin Diabetes Trial

por Soedamah-Muthu, Sabita S., Livingstone, Shona J., Charlton-Menys, Valentine, Betteridge, D. John, Hitman, Graham A., Neil, H. Andrew W., Bao, Weihang, DeMicco, David A., Preston, Gregory M., Fuller, John H., Stehouwer, Coen D. A., Schalkwijk, Casper G., Durrington, Paul N., Colhoun, Helen M.
Publicado 2015